Skip to main content

Breadcrumb

  1. Home

Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease

Blue Light Cystoscopy With Cysview® Registry

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Blue Light Cystoscopy With Cysview® Registry

Matched Targeted Therapy For High-Risk Leukemias and MDS

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Matched Targeted Therapy For High-Risk Leukemias and MDS

Comparison of Healthy Diets on Breast Cancer Markers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Comparison of Healthy Diets on Breast Cancer Markers

Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers

Real-time Activity Monitoring to Prevent Admissions During RadioTherapy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Real-time Activity Monitoring to Prevent Admissions During RadioTherapy

Low Dose Aprepitant for Patients Receiving Carboplatin

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Low Dose Aprepitant for Patients Receiving Carboplatin

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

Natural History of Oro-pharyngeal Cancer Precursors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Natural History of Oro-pharyngeal Cancer Precursors

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 260
  • Page 261
  • Page 262
  • Page 263
  • Page 264
  • Page 265
  • Page 266
  • Page 267
  • Page 268
  • …
  • Next page Next
  • Last page Last
Subscribe to